Relenza Divorce Coming? Developer Sues GSK For Lack Of Support
This article was originally published in The Pink Sheet Daily
Executive Summary
Biota, the Australian firm which developed the flu treatment, says that GlaxoSmithKline has stopped promoting Relenza and has declined to expand its label, allowing market share to “freefall.”